NCT04072081 is a NA clinical trial of Drug-coated balloon in Acute Myocardial Infarction, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT04072081?

NCT04072081 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT04072081?

Interventions in NCT04072081: Drug-coated balloon, Drug-eluting stent.

What condition does NCT04072081 study?

NCT04072081 studies Acute Myocardial Infarction.

Is NCT04072081 still recruiting?

NCT04072081 is currently status unknown. Last updated 28 August 2019.

Last reviewed 2019-08-28 · How we verify

NCT04072081

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drug-coated Balloon Versus Drug-eluting Stent in the Treatment of Coronary Artery Lesions in STEMI Patients in De Novo Coronary Lesions

Status unknown NA Last updated 28 August 2019

What this trial tests

NA trial testing Drug-coated balloon in Acute Myocardial Infarction in 4,000 participants. Status unknown.

Timeline

30 September 2019

Primary endpoint
30 September 2020

30 June 2021

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	4,000
Start date	30 September 2019
Primary completion	30 September 2020
Estimated completion	30 June 2021

Drugs / interventions tested

Drug-coated balloon
Drug-eluting stent

Conditions studied

Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

18 and older, any sex, with Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to find a DCB treatment for STEMI patients can achieve early and mid-term functional outcomes that are not inferior to DES, and realize the strategy of intervention without implantation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Drug-coated balloons in complex large-vessel coronary artery disease: a comprehensive review of current evidence and future perspectives.
Gitto M, Gabrielli A, Leone PP, Sanz-Sanchez J, et al · · 2026 · PMID 41815903 · DOI 10.3389/fcvm.2026.1731952
Contemporary Percutaneous Coronary Intervention in Diabetic Patients.
Tartaglia F, Filiberti G, Bernardini V, Gitto M, et al · · 2025 · PMID 41524061 · DOI 10.31083/rcm44861

Verify or expand the search:

Other trials of Drug-coated balloon

Trials testing the same drug.

NCT07587099 — Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREED · NA · not yet recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT05868564 — Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions · NA · not yet recruiting
NCT04937803 — Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS) · NA · completed
NCT03381872 — Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease · NA · active not recruiting

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04072081 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 28 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04072081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing